Invited Commentary for: A Report on Testicular Tissue Cryopreservation for Fertility Preservation in Children: Confirmation of Germ Cell Preservation and Few Surgical Complications

jpedsurg.org

The increasing survival rates for pediatric cancer patients have shifted the focus towards long-term quality of life, with fertility preservation emerging as a critical concern. Fertility preservation (FP) in adults undergoing treatment for malignancy has been well established, with sperm cryopreservation (“sperm banking”) a well-established option for men. For postpubertal women, oocyte and embryo cryopreservation are considered standard. In recent decades, the need for FP in prepubertal children at risk due to malignant or nonmalignant (hematologic, DSD, and other) conditions has been increasingly recognized (optimally prior to treatment), with advances in the options available [1,2].

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · May 2025 · 1 min read

In brief

This commentary addresses testicular tissue cryopreservation as an emerging fertility preservation option for prepubertal boys facing cancer treatment or other conditions threatening future fertility. As pediatric cancer survival improves, preserving reproductive potential before gonadotoxic therapy has become a key quality-of-life consideration, with this technique showing promise for germ cell preservation with minimal surgical risk.

Fertility preservation is now a critical quality-of-life concern for pediatric cancer survivors with improving survival rates.
Sperm banking is standard for postpubertal males; oocyte/embryo cryopreservation is standard for postpubertal females.
Prepubertal children with malignant or nonmalignant conditions increasingly need fertility preservation options before treatment.
Testicular tissue cryopreservation offers emerging fertility preservation for prepubertal boys unable to produce sperm samples.

Written by the GCMD Library team from the article.

Read it at the source ↗